Papers
List our Papers
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients.
Roscilli G, Cappelletti M, De Vitis C, Ciliberto G, Di Napoli A, Ruco L, Mancini R, Aurisicchio L.
J Transl Med. 2014 Feb 24;12:54. doi: 10.1186/1479-5876-12-54.
Immunogenicity and Therapeutic Efficacy of a Dual-Component Genetic Cancer Vaccine Cotargeting Carcinoembryonic Antigen and HER2/neu in Preclinical Models.
Aurisicchio L, Peruzzi D, Koo G, Wei WZ, La Monica N, Ciliberto G. Hum Gene Ther. 2014 Feb;25(2):121-31. doi: 10.1089/hum.2013.103. Epub 2013 Dec 21.
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients.
Roscilli G, Cappelletti M, De Vitis C, Ciliberto G, Di Napoli A, Ruco L, Mancini R, Aurisicchio L.
J Transl Med. 2014 Feb 24;12:54. doi: 10.1186/1479-5876-12-54.
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.
Noto A, Raffa S, De Vitis C, Roscilli G, Malpicci D, Coluccia P, Di Napoli A, Ricci A, Giovagnoli MR, Aurisicchio L, Torrisi MR, Ciliberto G, Mancini R. Cell Death Dis. 2013 Dec 5;4:e947. doi: 10.1038/cddis.2013.444.
New developments in cancer vaccines
Buonaguro L, Aurisicchio L, Buonaguro FM, Ciliberto G. Expert Rev Vaccines. 2013 Oct;12(10):1109-10. doi: 10.1586/17476348.2013.838013.